Y-mAbs Therapeutics - 53 Year Dividend History | YMAB
Historical dividend payout and yield for Y-mAbs Therapeutics (YMAB) since 1971. The current TTM dividend payout for Y-mAbs Therapeutics (YMAB) as of April 15, 2024 is $0.00. The current dividend yield for Y-mAbs Therapeutics as of April 15, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.629B |
$0.085B |
|
Y-mAbs Therapeutics Inc. is a biopharmaceutical company. It focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. The company's product pipeline consists of naxitamab and omburtamab which are in clinical stage. Y-mAbs Therapeutics Inc. is based in NEW YORK, USA.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
